How hormones affect women's smoking behavior
Contributions of Progestins Independently and Interactively with Contraceptive Estrogen to Nicotine Use
This study is looking at how synthetic hormones in birth control pills might affect women's cravings for nicotine and their ability to quit smoking, with the goal of finding better ways to help women stop smoking for good.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10710219 on NIH RePORTER |
What this research studies
This research investigates the role of synthetic hormones, specifically progestins and estrogens, in influencing nicotine use and smoking cessation in women. It examines how hormonal fluctuations can impact cravings and relapse rates, particularly focusing on the effects of oral contraceptives that contain these hormones. By studying the neurobiological mechanisms involved, the research aims to understand how these hormones interact with nicotine addiction in females, potentially leading to more effective cessation strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who smoke and are of reproductive age, particularly those using hormonal contraceptives.
Not a fit: Patients who do not smoke or are not of reproductive age may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved smoking cessation methods specifically tailored for women, addressing their unique hormonal influences.
How similar studies have performed: While there is existing research on smoking cessation, this specific investigation into the effects of synthetic hormones on nicotine use in women is novel and has not been extensively studied.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Gipson-Reichardt, Cassandra D — University of Kentucky
- Study coordinator: Gipson-Reichardt, Cassandra D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.